Glioma cells ectopically expressing CD133 increase neutrophil recruitment via the IL-1 signaling pathway both in vitro and in vivo, indicating that CD133-positive tumor-initiating cells might generate a unique TME through co-evolution with neutrophils 28. This evidence concerns the gene PROM1 and central nervous system cancer.